患有严重尿路病的新生儿体外膜氧化 (ECMO):单中心体验
Sébastien Faraj1, Pauline Clermidi2, Yohan Soreze3
1Sorbonne University, AP-HP, Armand Trousseau Hospital, Department of Visceral and Neonatal Pediatric Surgery, 26 Avenue du Dr Arnold Netter, 75012 Paris, France.
Journal of pediatric surgery
|November 23, 2025
概括
身体外膜氧化 (ECMO) 为患有严重泌尿病和呼吸衰竭的新生儿提供了可靠的救援. 虽然并发症是可以管理的,但长期的结果需要个性化护理.
科学领域:
- 新生儿重症监护中心
- 儿童心脏病学 儿童心脏病学
- 身体外生命支持器
背景情况:
- 体外膜氧化 (ECMO) 很少用于患有严重先天性泌尿病的新生儿.
- 这项研究检查了ECMO在5名新生儿的使用,这些新生儿患有与先天性泌尿病相关的危及生命的呼吸衰竭.
研究的目的:
- 描述ECMO对患有严重尿路病的新生儿支持的经验和结果.
- 评估ECMO在这种特定高风险人群中的安全性和有效性.
主要方法:
- 以ECMO (2015-2024) 治疗的五名新生儿的回顾性审查.
- 所有新生儿都患有严重的尿路病变和耐火性低氧症,需要ECMO.
- 采用了静脉动脉关节带管道;收集了手术,脏和神经结果的数据.
主要成果:
- 早期启动ECMO (平均寿命1天),平均时间为6天.
- 没有手术死亡;并发症包括一个电路故障和一个关血栓.
- 存活率为60% (3/5);脏和神经结果各不相同,一些患者患有慢性脏病或精神运动延迟.
结论:
- ECMO是一种可行的救援策略,用于选择尿路病变和呼吸衰竭的新生儿.
- 对于这一关键干预,并发症率是可以接受的.
- 多种多样的长期结果强调了定制,多学科的护理的必要性.
相关概念视频
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
165
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
165
01:25Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
180
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
180